(Q50478862)

English

A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.

scientific article published on 18 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

18

object named as

Toshifumi Hibi

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

author name string

Yoko Yokoyama

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Katsuyoshi Matsuoka

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Taku Kobayashi

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Koji Sawada

4

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tateshi Fujiyoshi

5

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Takafumi Ando

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Yoshifumi Ohnishi

7

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tetsuya Ishida

8

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Masashi Oka

9

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Masahiro Yamada

10

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Takashi Nakamura

11

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tomoko Ino

12

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Toyoko Numata

13

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Hirofumi Aoki

14

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Jun-Ichi Sakou

15

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Masahiro Kusada

16

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tomoki Maekawa

17

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

publication date

18 February 2014

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Journal of Crohn's and Colitis

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

8

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

9

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

981-991

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Clinical aspects and pathophysiology of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Defects in mucosal immunity leading to ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Cortisone and corticotrophin in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Side effects of corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Preliminary data on the use of apheresis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Fluctuations in peripheral blood leukocyte and platelet counts and leukocyte recruitment with large volume leukocytapheresis in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Clinical implications of mucosal healing for the management of IBD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

From randomized controlled trials to observational studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Identifiers

10.1016/J.CROHNS.2014.01.027

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50478862&oldid=1569245326"